Skip to Content
Stock Strategist

A Shift in Health-Care M&A Activity

Recent deals have been driven more by tax strategies than therapeutic synergies.

Mentioned: , , , , , , , , ,

Traditionally, mergers and acquisitions in the health-care sector involve companies seeking to better leverage their existing infrastructure. Companies tend to stick to therapeutic areas they're already in, where they have a sales force and relationships with physicians. More recently, however, we've seen companies create value by making tax-driven deals--either doing a tax inversion (in which a firm acquires a company in a lower-taxed country and then re-incorporates to that country) or buying overseas companies facing higher tax rates and moving those acquisitions to their home base.

To build an understanding of what the rest of 2014 might hold for M&A activity in health care, I recently talked with Morningstar health-care analysts Damien Conover, David Krempa, and Michael Waterhouse on May 31. Our discussion has been edited for clarity and length.

Basili Alukos does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.